Roswitha Verwer and Dr. Muskaan Bhan share their journey from preclinical validation through regulatory approval, currently at TRL4, pursuing CE Mark and FDA De Novo. The conversation offers insights into how real-time biomarker data can transform women’s reproductive health while overcoming investor skepticism, taboo, and market barriers when solving decades-old clinical blind spots in women’s health.

“Roswitha Verwer en YON E Health bouwen aan een nieuwe generatie FemTech-innovatie door real-time data over vaginale gezondheid toegankelijk te maken voor vrouwen.”

“The investment will support the development of YON E Health’s smart vaginal health device that measures pH and temperature, two biomarkers linked to fertility, infection risk, and reproductive health.”

Peter Kovacs features Roswitha Verwer and Muskaan Bhan on Clinical Capital Conversations, exploring how she scales FemTech with precision, purpose, and science-driven innovation in women’s health.

“YON E Health has raised pre-seed funding led by PMK-Group to advance its smart vaginal health device, tracking pH and temperature for fertility, infection risk, and reproductive wellness, as Europe’s FemTech sector gains momentum with data-driven, clinical-grade innovation.”

“Yon E Health has raised €250k in pre-seed funding to develop a smart vaginal health sensor measuring pH and temperature, helping women track fertility, infection risk, and reproductive wellbeing with real-time, clinical-grade data ahead of medical trials”

“YON E Health has raised pre-seed funding led by PMK-Group to advance its smart vaginal health device, tracking pH and temperature for fertility, infection risk, and reproductive wellness, as Europe’s FemTech sector gains momentum with data-driven, clinical-grade innovation.”

“YON E Health has raised €250,000 in pre-seed funding to develop an at-home device measuring vaginal pH and temperature, helping women track fertility, infection risk, and reproductive health with real-time, science-backed insights.”

“YON E Health raises €250k pre-Seed to advance a first-of-its-kind smart vaginal health device measuring pH and temperature for fertility, infection risk, and reproductive wellbeing, strengthening Europe’s growing FemTech market with science-backed, women-centered innovation.”

YON E Health has raised €250k in pre-seed funding to advance its vaginal health device, highlighting growing investor interest in European femtech and smarter women’s health solutions designed to improve monitoring, prevention and personalised reproductive care.

“Roswitha Verwer, CEO of YON E Health, is building data-driven solutions to transform women’s health. Driven by lived experience, she is breaking taboos in vaginal health and fertility, turning real-time biomarker insights into personalized care for women worldwide.”

“Roswitha Verwer, CEO of YON E Health, is pioneering data-driven innovation in women’s health. She leads the development of a smart vaginal health device, transforming taboo topics into real-time insights for fertility, prevention, and personalized care.”

YON E Health was highlighted by Founders Amplified for its medical device innovation advancing vaginal health data, FemTech research, and stigma-free women’s healthcare.

Founder Roswitha Verwer shares insights on FemTech, vaginal health innovation, fertility awareness, resilience, and values-driven leadership on the Productive Passions Podcast.

Explores the “female paradox” (women live longer yet spend more life in poor health), the economic cost of the women’s health gap, and why the European Femtech Map was created, tracking 10 femtech categories and where companies and communities are growing fastest.

Roswitha Verwer, Founder of YON E Health, joins The Founders Atlas podcast to discuss FemTech innovation, reproductive health data, and building a mission-driven women’s health startup.